The project was aimed at establishing predictive in vitro and in vivo platforms to select promising HIV therapeutic vaccine candidates and to evaluate a therapeutic vaccine strategy to improve the management of perinatally HIV-infected children.

ROLE OF THE FOUNDATION
The Foundation provided resources to CVBF with the aim of making available its expertise to coordinate all ethical and regulatory activities related to clinical studies, as well as the collection and sharing of health data.

FUNDED BY: Fondazione PENTA Onlus​

DURATION: 08/02/2016 – 31/08/2024